Lista de obras -

ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome

artículo científico publicado en 2011

Accumulation of Segmental Alterations Determines Progression in Neuroblastoma

artículo científico publicado en 2010

Cholinergic switch associated with morphological differentiation in neuroblastoma

artículo científico publicado en 2009

Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosis

artículo científico publicado en 2018

Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN.

artículo científico publicado en 2014

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

artículo científico publicado en 2010

Cytopathologie des tumeurs malignes du blastème

artículo científico publicado en 2004

Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis.

artículo científico publicado en 2015

Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients

Emergence of new ALK mutations at relapse of neuroblastoma

artículo científico publicado en 2014

Extra-renal non-cerebral rhabdoid tumours

scientific article published on September 2008

Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumors.

artículo científico publicado en 2016

Fine-needle aspiration as a diagnostic technique in 50 cases of primary Ewing sarcoma/peripheral neuroectodermal tumor. Institut Curie's experience

artículo científico publicado en 2010

Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma.

artículo científico publicado en 2016

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

artículo científico publicado en 1998

Opsoclonus-myoclonus in children associated or not with neuroblastoma.

artículo científico publicado en 2010

Overall genomic pattern is a predictor of outcome in neuroblastoma

artículo científico publicado en 2009

Patient management in pediatric oncology during the COVID-19 pandemic: Report from francophone Africa

scientific article published on 02 September 2020

Pediatric Patient With Renal Cell Carcinoma Treated by Successive Antiangiogenics Drugs: A Case Report and Review of the Literature

artículo científico publicado en 2017

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

artículo científico publicado en 2009

Quality assessment of genetic markers used for therapy stratification.

artículo científico publicado en 2003

Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival.

artículo científico publicado en 2017

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

artículo científico publicado en 2015

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

artículo científico publicado en 2011

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

artículo científico publicado en 2008

The International Neuroblastoma Risk Groups (INRG): a preliminary report

artículo científico publicado en 1997

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.

artículo científico publicado en 2008

VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de l'Enfant (SFCE).

artículo científico publicado en 2009

Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma

artículo científico publicado en 2017

[Genetic alterations in neuroblastoma and their usefulness for clinical management]

artículo científico publicado en 2011

Lista de obras de

ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome

Accumulation of Segmental Alterations Determines Progression in Neuroblastoma

Cholinergic switch associated with morphological differentiation in neuroblastoma

Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosis

Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN.

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

Cytopathologie des tumeurs malignes du blastème

Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis.

Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients

Emergence of new ALK mutations at relapse of neuroblastoma

Extra-renal non-cerebral rhabdoid tumours

Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumors.

Fine-needle aspiration as a diagnostic technique in 50 cases of primary Ewing sarcoma/peripheral neuroectodermal tumor. Institut Curie's experience

Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma.

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

Opsoclonus-myoclonus in children associated or not with neuroblastoma.

Overall genomic pattern is a predictor of outcome in neuroblastoma

Patient management in pediatric oncology during the COVID-19 pandemic: Report from francophone Africa

Pediatric Patient With Renal Cell Carcinoma Treated by Successive Antiangiogenics Drugs: A Case Report and Review of the Literature

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

Quality assessment of genetic markers used for therapy stratification.

Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival.

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

The International Neuroblastoma Risk Groups (INRG): a preliminary report

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.

VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de l'Enfant (SFCE).

Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma

[Genetic alterations in neuroblastoma and their usefulness for clinical management]